AstraZeneca Discloses US Investigation Into Heart Drug Trial

UK pharmaceutical giant AstraZeneca PLC disclosed Thursday that the U.S. Department of Justice had opened an investigation into a clinical trial that was the basis for regulatory approval of its new...

Already a subscriber? Click here to view full article